New You, Inc. (NWYU) Income Statement Analysis

See more : MRK Holdings Inc. (9980.T) Income Statement Analysis – Financial Results

Complete financial analysis of New You, Inc. (NWYU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of New You, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.

You may be interested

Royal Bank of Canada (RBCPF) Income Statement Analysis – Financial Results
Champion Electric Metals Inc. (1QB0.F) Income Statement Analysis – Financial Results
Overseas Shipholding Group Inc (OGSRW) Income Statement Analysis – Financial Results
Quick Heal Technologies Limited (QUICKHEAL.NS) Income Statement Analysis – Financial Results
ntc industries limited (NTCIND.BO) Income Statement Analysis – Financial Results

New You, Inc. (NWYU)

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Website: https://newyoupro.com

About New You, Inc.

New You, Inc., through its subsidiary, New You LLC, develops and markets cannabidiol (CBD) hemp oil-based products. The company offers DROPS beverage or liquid CBD products; CB2 & CBD 2 Plus, a multi spectrum hemp-extracted CBD and beta-caryophyllene; Drops for pets; Caffe Canna, an organic cannabinoid-infused non-GMO dark roast coffee; and ABSORB, a root and rice flour veggie capsule. It also provides RELEASE; Drops FX, a blend of CBD and Vitamins B3, B6, B9, and B12 for use in drink or liquid; and Drops FX Sleep, a blend of CBD, gamma-amino butyric acid, melatonin, and valerian root; NanoX, a water soluble full spectrum DBD made with Purified Water; and The Cream, a topical skin cream. The company markets and sells its products through multi-level marketing and direct sales force to independent business owners. New You, Inc. is based in Carlsbad, California.

Metric	2020	2019	2018	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Revenue	2.01M	2.83M	898.15K	216.38K	526.65K	648.68K	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	285.16K	454.76K	197.42K	22.13K	64.60K	112.44K	0.00	0.00	0.00	0.00	0.00	38.40K	28.82M	0.00
Gross Profit	1.72M	2.38M	700.74K	194.25K	462.05K	536.24K	0.00	0.00	0.00	0.00	0.00	-38.40K	-28.82M	0.00
Gross Profit Ratio	85.80%	83.94%	78.02%	89.77%	87.73%	82.67%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	4.39M	3.04M	689.99K	2.21M	4.15M	1.41M	385.43K	206.88K	28.78K	14.43K	101.23K	51.84K	27.17K	20.00K
Selling & Marketing	571.34K	1.03M	437.95K	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	4.96M	4.07M	1.13M	2.21M	4.15M	1.41M	385.43K	206.88K	28.78K	14.43K	101.23K	51.84K	27.17K	20.00K
Other Expenses	0.00	1.25M	0.00	1.95K	1.80K	1.05K	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Expenses	4.96M	4.07M	1.13M	2.21M	4.15M	1.41M	385.43K	206.88K	28.78K	14.43K	101.23K	51.84K	27.17K	20.00K
Cost & Expenses	5.24M	4.52M	1.33M	2.24M	4.21M	1.53M	385.43K	206.88K	28.78K	14.43K	101.23K	51.84K	27.17K	20.00K
Interest Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	744.15K	0.00	0.00	594.93K	628.11K	1.28M	81.02K	30.92K	1.16K	-14.43K	-101.23K	-51.84K	-27.17K	0.00
Depreciation & Amortization	59.72K	110.08K	2.41K	-5.53M	44.63K	-1.66M	0.00	0.00	0.00	0.00	-50.00K	-5.00K	-573.00	0.00
EBITDA	-3.24M	-1.58M	-424.79K	-7.55M	-3.64M	-3.69M	-876.60K	-206.88K	-28.78K	-14.43K	-302.45K	-56.84K	-55.48K	-20.00K
EBITDA Ratio	-158.11%	-55.83%	-47.30%	-3,488.04%	-691.70%	-391.35%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Income	-3.24M	-1.69M	-427.21K	-2.02M	-3.69M	-877.65K	-385.43K	-206.88K	-28.78K	-14.43K	-101.23K	-51.84K	-27.17K	-20.00K
Operating Income Ratio	-161.08%	-59.72%	-47.56%	-933.70%	-700.17%	-135.30%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Total Other Income/Expenses	-1.81M	0.00	0.00	-6.31M	-6.31M	-125.82K	-3.43M	-30.92K	-1.16K	0.00	-50.00K	-5.00K	-573.00	0.00
Income Before Tax	-5.05M	-1.69M	-427.21K	-8.33M	-4.24M	-3.82M	-466.45K	-237.80K	-29.94K	-14.43K	-151.23K	-56.84K	-27.74K	-20.00K
Income Before Tax Ratio	-251.23%	-59.72%	-47.56%	-3,848.28%	-805.19%	-588.42%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Income Tax Expense	800.00	800.00	800.00	-182.63K	32.19K	2.94M	0.00	237.80K	29.94K	14.43K	151.23K	56.84K	27.74K	0.00
Net Income	-5.05M	-1.69M	-428.01K	-8.14M	-4.27M	-6.76M	-466.45K	-475.60K	-59.88K	-28.86K	-302.45K	-113.68K	-55.48K	-20.00K
Net Income Ratio	-251.27%	-59.75%	-47.65%	-3,763.88%	-811.30%	-1,041.54%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	-0.15	-0.06	-0.05	-55.07	-3.81K	-7.78K	-971.76	-990.84	-124.76	-60.12	-630.11	-236.84	-115.57	-41.67
EPS Diluted	-0.15	-0.06	-0.05	-55.07	-3.81K	-7.78K	-971.76	-990.84	-124.76	-60.12	-630.11	-236.84	-115.57	-41.67
Weighted Avg Shares Out	34.48M	26.34M	8.22M	147.90K	1.12K	868.00	480.00	480.00	480.00	480.00	480.00	480.00	480.00	480.00
Weighted Avg Shares Out (Dil)	34.48M	26.34M	8.22M	147.90K	1.12K	868.00	480.00	480.00	480.00	480.00	480.00	480.00	480.00	480.00

New You, Inc. Subsidiary ST Brands Enters European Luxury Skin Care Market with Activation of Primus CBD Skincare

June 22, 2021globenewswire.com

CARLSBAD, Calif., June 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- New You, Inc. (OTCQB: NWYU ) today announced that its wholly-owned subsidiary, ST Brands, enters the European skin care industry through its Stock Purchase Agreement with Primus Skincare, a...

New You, Inc. Appoints John Driscoll Chief Financial Officer and Member of Board of Directors

June 17, 2021globenewswire.com

CARLSBAD, CA, June 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- New You, Inc. (OTCQB: NWYU ) today announced its appointment of John Driscoll , 54, as chief financial officer (CFO), and member of the company's board of directors, effective June 15,...